(Q35695811)

9 August 2017

title

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience (English)

1 reference

adaptive radiation therapy

9 August 2017

main subject

0 references

1 reference

12

Timothy M Pawlik

1 reference

9 August 2017

14

Matthew J Weiss

1 reference

9 August 2017

5

John L Cameron

1 reference

9 August 2017

Shalini Moningi

1

1 reference

9 August 2017

Avani S Dholakia

2

1 reference

9 August 2017

Siva P Raman

3

1 reference

9 August 2017

Amanda Blackford

4

1 reference

9 August 2017

Dung T Le

6

1 reference

9 August 2017

Ana M C De Jesus-Acosta

7

1 reference

9 August 2017

Amy Hacker-Prietz

8

1 reference

9 August 2017

Lauren M Rosati

9

1 reference

9 August 2017

Ryan K Assadi

10

1 reference

9 August 2017

Shirl Dipasquale

11

1 reference

9 August 2017

Lei Zheng

13

1 reference

9 August 2017

Daniel A Laheru

15

1 reference

9 August 2017

Christopher L Wolfgang

16

1 reference

9 August 2017

Joseph M Herman

17

1 reference

9 August 2017

publication date

7 January 2015

1 reference

Annals of Surgical Oncology

9 August 2017

published in

1 reference

9 August 2017

volume

22

1 reference

9 August 2017

issue

7

1 reference

9 August 2017

page(s)

2352-2358

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-014-4274-5

9 August 2017

exact match

0 references

cites work

Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

12 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Stereotactic body radiation therapy for nonresectable tumors of the pancreas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Stereotactic body radiation therapy in multiple organ sites

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4459890

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

25 September 2018

1 reference

12 December 2020

Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas

1 reference

12 December 2020

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma

1 reference

12 December 2020

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

1 reference

12 December 2020

10.1245/S10434-014-4274-5

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference